24-norursodeoxycholic acid has been researched along with Liver Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blomenkamp, KS; Fickert, P; Tang, Y; Teckman, JH; Trauner, M | 1 |
| Arab, JP; Arrese, M; Cabrera, D | 1 |
| Claudel, T; Fickert, P; Fuchs, C; Halilbasic, E; Hofer, H; Kazemi-Shirazi, L; Kienbacher, C; Krones, E; Moustafa, T; Munda, P; Paumgartner, G; Pollheimer, M; Steinacher, D; Trauner, M; Traussnigg, S | 1 |
2 review(s) available for 24-norursodeoxycholic acid and Liver Diseases
| Article | Year |
|---|---|
UDCA, NorUDCA, and TUDCA in Liver Diseases: A Review of Their Mechanisms of Action and Clinical Applications.
Topics: Bile Acids and Salts; Cholestasis; Humans; Liver; Liver Diseases; Taurochenodeoxycholic Acid; Ursodeoxycholic Acid | 2019 |
Potential of nor-Ursodeoxycholic Acid in Cholestatic and Metabolic Disorders.
Topics: Animals; Bile Duct Diseases; Humans; Liver Diseases; Metabolic Diseases; Signal Transduction; Ursodeoxycholic Acid | 2015 |
1 other study(ies) available for 24-norursodeoxycholic acid and Liver Diseases
| Article | Year |
|---|---|
NorUDCA promotes degradation of α1-antitrypsin mutant Z protein by inducing autophagy through AMPK/ULK1 pathway.
Topics: Adenylate Kinase; alpha 1-Antitrypsin; Animals; Autophagy; Autophagy-Related Protein-1 Homolog; Disease Models, Animal; HeLa Cells; Humans; Intracellular Signaling Peptides and Proteins; Liver; Liver Diseases; Mice; Mutant Proteins; Proteolysis; RNA, Messenger; Signal Transduction; TOR Serine-Threonine Kinases; Ursodeoxycholic Acid | 2018 |